263 related articles for article (PubMed ID: 27061760)
1. Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review.
Mehta H; Gillies MC; Fraser-Bell S
Clin Exp Ophthalmol; 2016 May; 44(4):335-9. PubMed ID: 27061760
[TBL] [Abstract][Full Text] [Related]
2. A review of therapies for diabetic macular oedema and rationale for combination therapy.
Amoaku WM; Saker S; Stewart EA
Eye (Lond); 2015 Sep; 29(9):1115-30. PubMed ID: 26113500
[TBL] [Abstract][Full Text] [Related]
3. RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Bressler SB; Melia M; Glassman AR; Almukhtar T; Jampol LM; Shami M; Berger BB; Bressler NM;
Retina; 2015 Dec; 35(12):2516-28. PubMed ID: 26035510
[TBL] [Abstract][Full Text] [Related]
4. Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.
Mohamed QA; Fletcher EC; Buckle M
BMJ Clin Evid; 2016 Mar; 2016():. PubMed ID: 27031563
[TBL] [Abstract][Full Text] [Related]
5. Anti-vascular endothelial growth factor agents for diabetic maculopathy.
Salam A; DaCosta J; Sivaprasad S
Br J Ophthalmol; 2010 Jul; 94(7):821-6. PubMed ID: 19556214
[TBL] [Abstract][Full Text] [Related]
6. Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up.
Romero-Aroca P; de la Riva-Fernandez S; Valls-Mateu A; Sagarra-Alamo R; Moreno-Ribas A; Soler N; Puig D
BMC Ophthalmol; 2016 Aug; 16():136. PubMed ID: 27491545
[TBL] [Abstract][Full Text] [Related]
7. Treatment Patterns of Anti-Vascular Endothelial Growth Factor and Laser Therapy Among Patients with Diabetic Macular Edema.
Jiang S; Barner JC; Park C; Ling YL
J Manag Care Spec Pharm; 2015 Sep; 21(9):735-41. PubMed ID: 26308221
[TBL] [Abstract][Full Text] [Related]
8. Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: A Bayesian network meta-analysis.
Wu Y; Ai P; Ai Z; Xu G
Biomed Pharmacother; 2018 Jan; 97():293-299. PubMed ID: 29091878
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injections and diabetic macular edema: actual and new therapeutic options.
Pescosolido N; Pranno F; Buomprisco G
Curr Diabetes Rev; 2013 Nov; 9(6):491-8. PubMed ID: 24160355
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review.
Massa H; Nagar AM; Vergados A; Dadoukis P; Patra S; Panos GD
J Int Med Res; 2019 Jan; 47(1):31-43. PubMed ID: 30556449
[TBL] [Abstract][Full Text] [Related]
11. Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema.
Bressler SB; Glassman AR; Almukhtar T; Bressler NM; Ferris FL; Googe JM; Gupta SK; Jampol LM; Melia M; Wells JA;
Am J Ophthalmol; 2016 Apr; 164():57-68. PubMed ID: 26802783
[TBL] [Abstract][Full Text] [Related]
12. Management paradigms for diabetic macular edema.
Mitchell P; Wong TY;
Am J Ophthalmol; 2014 Mar; 157(3):505-13.e1-8. PubMed ID: 24269850
[TBL] [Abstract][Full Text] [Related]
13. How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema?
Blindbaek SL; Peto T; Grauslund J
Acta Ophthalmol; 2019 Jun; 97(4):339-346. PubMed ID: 30575304
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Options in Refractory Diabetic Macular Oedema.
Shah SU; Maturi RK
Drugs; 2017 Apr; 77(5):481-492. PubMed ID: 28197794
[TBL] [Abstract][Full Text] [Related]
15. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
Mukkamala L; Bhagat N; Zarbin MA
Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
[TBL] [Abstract][Full Text] [Related]
16. Management of diabetic macular edema in Japan: a review and expert opinion.
Terasaki H; Ogura Y; Kitano S; Sakamoto T; Murata T; Hirakata A; Ishibashi T
Jpn J Ophthalmol; 2018 Jan; 62(1):1-23. PubMed ID: 29210010
[TBL] [Abstract][Full Text] [Related]
17. [Choice of treatment for diabetic macular edema].
Yang L; Zhang J
Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):724-728. PubMed ID: 29050184
[TBL] [Abstract][Full Text] [Related]
18. Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.
Bressler SB; Almukhtar T; Bhorade A; Bressler NM; Glassman AR; Huang SS; Jampol LM; Kim JE; Melia M;
JAMA Ophthalmol; 2015 May; 133(5):589-97. PubMed ID: 25719991
[TBL] [Abstract][Full Text] [Related]
19. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
Ajlan RS; Silva PS; Sun JK
Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study).
Heng LZ; Sivaprasad S; Crosby-Nwaobi R; Saihan Z; Karampelas M; Bunce C; Peto T; Hykin PG
Br J Ophthalmol; 2016 Jun; 100(6):802-7. PubMed ID: 26472406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
